Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2001, p. 1964-1971, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.1964-1971.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Pseudomonas aeruginosa Reveals High
Intrinsic Resistance to Penem Antibiotics: Penem Resistance
Mechanisms and Their Interplay
Kiyomi
Okamoto,
Naomasa
Gotoh,* and
Takeshi
Nishino
Department of Microbiology, Kyoto
Pharmaceutical University, Yamashina, Kyoto 607-8414, Japan
Received 10 October 2000/Returned for modification 5 February
2001/Accepted 7 April 2001
Pseudomonas aeruginosa exhibits high intrinsic
resistance to penem antibiotics such as faropenem, ritipenem, AMA3176,
sulopenem, Sch29482, and Sch34343. To investigate the mechanisms
contributing to penem resistance, we used the laboratory strain PAO1 to
construct a series of isogenic mutants with an impaired multidrug
efflux system MexAB-OprM and/or impaired chromosomal AmpC
-lactamase. The outer membrane barrier of PAO1 was partially
eliminated by inducing the expression of the plasmid-encoded
Escherichia coli major porin OmpF. Susceptibility tests
using the mutants and the OmpF expression plasmid showed that
MexAB-OprM and the outer membrane barrier, but not AmpC
-lactamase,
are the main mechanisms involved in the high intrinsic penem resistance
of PAO1. However, reducing the high intrinsic penem resistance of PAO1
to the same level as that of penem-susceptible gram-negative bacteria
such as E. coli required the loss of either both MexAB-OprM
and AmpC
-lactamase or both MexAB-OprM and the outer membrane
barrier. Competition experiments for penicillin-binding proteins (PBPs)
revealed that the affinity of PBP 1b and PBP 2 for faropenem were about
1.8- and 1.5-fold lower, than the respective affinity for imipenem. Loss of the outer membrane barrier, MexAB, and AmpC
-lactamase increased the susceptibility of PAO1 to almost all penems tested compared to the susceptibility of the AmpC-deficient PAO1 mutants to
imipenem. Thus, it is suggested that the high intrinsic penem resistance of P. aeruginosa is generated from the interplay
among the outer membrane barrier, the active efflux system, and AmpC
-lactamase but not from the lower affinity of PBPs for penems.
*
Corresponding author. Mailing address: Department of
Microbiology, Kyoto Pharmaceutical University, Yamashina, Kyoto
607-8414, Japan. Phone: 81-75-595-4642. FAX: 81-75-583-2230. E-mail:
ngotoh{at}mb.kyoto-phu.ac.jp.
Antimicrobial Agents and Chemotherapy, July 2001, p. 1964-1971, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.1964-1971.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wolter, D. J., Black, J. A., Lister, P. D., Hanson, N. D.
(2009). Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype. J Antimicrob Chemother
64: 294-300
[Abstract]
[Full Text]
-
Naas, T., Namdari, F., Bogaerts, P., Huang, T.-D., Glupczynski, Y., Nordmann, P.
(2008). Genetic Structure Associated with blaOXA-18, Encoding a Clavulanic Acid-Inhibited Extended-Spectrum Oxacillinase. Antimicrob. Agents Chemother.
52: 3898-3904
[Abstract]
[Full Text]
-
Naas, T., Cuzon, G., Villegas, M.-V., Lartigue, M.-F., Quinn, J. P., Nordmann, P.
(2008). Genetic Structures at the Origin of Acquisition of the {beta}-Lactamase blaKPC Gene. Antimicrob. Agents Chemother.
52: 1257-1263
[Abstract]
[Full Text]
-
Gettig, J. P, Crank, C. W, Philbrick, A. H
(2008). Faropenem Medoxomil. The Annals of Pharmacotherapy
42: 80-90
[Abstract]
[Full Text]
-
Wexler, H. M., Engel, A. E., Glass, D., Li, C.
(2005). In Vitro Activities of Doripenem and Comparator Agents against 364 Anaerobic Clinical Isolates. Antimicrob. Agents Chemother.
49: 4413-4417
[Abstract]
[Full Text]
-
Salunkhe, P., Smart, C. H. M., Morgan, J. A. W., Panagea, S., Walshaw, M. J., Hart, C. A., Geffers, R., Tummler, B., Winstanley, C.
(2005). A Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa Displays Enhanced Virulence and Antimicrobial Resistance. J. Bacteriol.
187: 4908-4920
[Abstract]
[Full Text]
-
Girlich, D., Naas, T., Nordmann, P.
(2004). Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
48: 2043-2048
[Abstract]
[Full Text]
-
Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., Plesiat, P.
(2004). Clinical Strains of Pseudomonas aeruginosa Overproducing MexAB-OprM and MexXY Efflux Pumps Simultaneously. Antimicrob. Agents Chemother.
48: 1797-1802
[Abstract]
[Full Text]
-
Hirakawa, H., Nishino, K., Yamada, J., Hirata, T., Yamaguchi, A.
(2003). {beta}-Lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Antimicrob Chemother
52: 576-582
[Abstract]
[Full Text]
-
Aubert, D., Naas, T., Nordmann, P.
(2003). IS1999 Increases Expression of the Extended-Spectrum {beta}-Lactamase VEB-1 in Pseudomonas aeruginosa. J. Bacteriol.
185: 5314-5319
[Abstract]
[Full Text]
-
Van Bambeke, F., Glupczynski, Y., Plesiat, P., Pechere, J. C., Tulkens, P. M.
(2003). Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother
51: 1055-1065
[Full Text]
-
Savli, H., Karadenizli, A., Kolayli, F., Gundes, S., Ozbek, U., Vahaboglu, H.
(2003). Expression stability of six housekeeping genes: a proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-PCR. J Med Microbiol
52: 403-408
[Abstract]
[Full Text]
-
Okamoto, K., Gotoh, N., Nishino, T.
(2002). Extrusion of Penem Antibiotics by Multicomponent Efflux Systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
46: 2696-2699
[Abstract]
[Full Text]